The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Molex's revenues will grow 9.6% and EPS will increase 2.9%.
The average estimate for revenue is $917.3 million. On the bottom line, the average EPS estimate is $0.35.
Last quarter, Molex logged revenue of $967.7 million. GAAP reported sales were 13% higher than the prior-year quarter's $857.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.39. GAAP EPS of $0.39 for Q2 were 8.3% higher than the prior-year quarter's $0.36 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 29.9%, 80 basis points worse than the prior-year quarter. Operating margin was 11.2%, 40 basis points worse than the prior-year quarter. Net margin was 7.3%, 20 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $3.76 billion. The average EPS estimate is $1.56.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 132 members out of 147 rating the stock outperform, and 15 members rating it underperform. Among 44 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 41 give Molex a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Molex is hold, with an average price target of $26.77.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Molex. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Molex to My Watchlist.